Qiumei Yang

City:

Shanghai

Country:

China

Published Applications:

Last publication date:

2026-06-18

Top Assignees for applications by Qiumei Yang

The entities that hold a legal rights for patent applications filed by inventor Yang Qiumei:

I-Mab Biopharma US Limited 3 Gaithersburg, MD United States
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2 PHILADELPHIA, PA United States
NOVARTIS AG 2 Basel, Switzerland

Recent patent applications by Yang Qiumei

Qiumei Yang from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-18

US20260166166A1

Human necessities

HUMANIZED L1CAM ANTIBODY-DRUG CONJUGATE

#2 | 2026-06-04

US20260152552A1

Chemistry; metallurgy

NOVEL ANTI-L1CAM ANTIBODY

#3 | 2023-02-16

US20230052970A1

Chemistry; metallurgy

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EXPRESSING CHIMERIC ANTIGEN RECEPTOR

#4 | 2021-09-16

US20210284724A1

Chemistry; metallurgy

Anti-CXCL13 antibodies for treating autoimmune diseases and cancer

#5 | 2021-07-01

US20210198368A1

Chemistry; metallurgy

MULTISPECIFIC MOLECULES TARGETING CLL-1

#6 | 2020-12-24

US20200399360A1

Chemistry; metallurgy

Anti-CXCL13 antibodies

#7 | 2020-11-05

US20200347146A1

Chemistry; metallurgy

Anti-CD73 anti-PD-L1 bispecific antibodies

#8 | 2020-07-09

US20200215171A1

Human necessities

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

#9 | 2018-05-03

US20180118834A1

Chemistry; metallurgy

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor

#10 | 2016-02-25

US20160051651A1

Human necessities

Treatment of cancer using a CLL-1 chimeric antigen receptor

InventorID:

1450004 ⎘